Bibliography for: "Lannett Company receives approval for doxycycline monohydrate"

"Lannett Company receives approval for doxycycline monohydrate". Journal of Drugs in Dermatology. FindArticles.com. 03 Jan, 2010. http://findarticles.com/p/articles/mi_m0PDG/is_2_5/ai_n16085964/

Journal of Drugs in Dermatology

View more issues:

Articles in Feb, 2006 issue of Journal of Drugs in Dermatology

• Indoor tanning—magnitude of the health issue
• Photodynamic therapy for the treatment of erythema, papules, pustules, and severe flushing consistent with rosacea
  by Bruce Katz
• HPV vaccines extremely promising in preventing cervical cancer
• Treatment of hyperpigmentation-melasma with photodynamic therapy
  by LindaSusan Marcus
• Infliximab associated new-onset psoriasis
  by David R. Adams
• Sebazole NDA submitted to FDA
• Safety and efficacy study of ICXP007 with compression bandaging for the treatment of non-infected venous leg ulcers
• Effect of anti-IgE in chronic urticaria
• Bilateral comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% 5-fluorouracil cream in the treatment of actinic keratoses of the face and scalp
  by Stacy R. Smith
• Interferon alpha 2b vs. observation in patients with stage IIb/III melanoma
• Treatment of melasma with Jessner's solution vs. trichloroacetic acid
• Neoadjuvant imatinib in dermatofibrosarcoma protuberans
• Open-label safety study to evaluate imiquimod cream, 5% for large areas of actinic keratosis
• Interferon-alpha 2a vs. cyclosporin a for severe ocular Behcet's disease
• Imiquimod 5% cream in plaque-type morphea: a pilot, prospective open-label study
• TH9507 in patients with HIV-associated lipodystrophy
• Intralesional PV-10 chemoablation of metastatic melanoma
• An unusual presentation of refractory cutaneous Langerhans cell histiocytosis in an adult
  by Suneeta S. Walia
• Lannett Company receives approval for doxycycline monohydrate
• Intralesional treatment with interleukin-2 in soft tissue melanom metastases
• Infliximab to treat dermatomyositis and polymyositis
• Efficacy and safety of adalimumab in subjects with moderate to severe chronic plaque psoriasis
• Current treatments of actinic keratosis
  by Michael H. Gold
• Mechanisms of action of new treatment modalities for actinic keratosis
  by Brian Berman
• Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicenter, double-blind trial
• Topical NF-kappa [beta] Decoy in the treatment of atopic dermatitis
• A study of the use of methotrexate in the treatment of chronic idiopathic urticaria
• Photodynamic therapy for perioral dermatitis
  by Donald F. Richey
• The use of photodynamic therapy in dermatology: results of a consensus conference
  by Mark S. Nestor
• New class of antibiotic appears promising in the treatment of skin infections
• Non-cutting laser therapy in the treatment of acne
• Evaluation of the clinical effectiveness of a Collagen-ORC Antimicrobial matrix in full-thickness, neuropathic diabetic foot ulcers
• Acitretin and etanercept in psoriasis
• Broad area photodynamic therapy for treatment of multiple basal cell carcinomas in a patient with nevoid basal cell carcinoma syndrome
  by Anne M. Chapas
• Effect of Sacchachitin on healing of a chronic wound
• Curcuminoids for the treatment of chronic psoriasis vulgaris
• Zostavax receives favorable reviews from FDA
• Etanercept with tacrolimus for psoriasis
• Study evaluating etanercept and methotrexate in plaque psoriasis
• Safety update on commonly used psychotropic medications in dermatology
  by Daniel Navi
• Rapid growth of Merkel cell carcinoma after treatment with rituximab
  by Marla L. Wirges
• INVANZ approved for complicated foot infection in diabetic patients
• Bevacizumab to treat Kaposi's sarcoma in HIV-positive and HIV-negative patients
• Efficacy of elidel cream on erosive oral lichen planus
• The clinical impact of vehicle technology using a patented formulation of benzoyl peroxide 5%/clindamycin 1% gel: comparative assessments of skin tolerability and evaluation of combination use with a topical retinoid
  by James Q. Del Rosso
• Possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo
• Schools in Pharmacology
  by Noah Scheinfeld
• Terbinafine compared to griseofulvin in children with tinea capitis
• One-week treatment with 0.5% fluorouracil cream prior to cryosurgery in patients with actinic keratoses: a double-blind, vehicle-controlled, long-term study
  by J. Jorizzo
• Poiklodermatous variant of mycosis fungoides
  by Iqbal A. Bukhari
• Dyax and Genzyme initiate phase III trial of DX-88 for the treatment of hereditary angioedema
• Leptin to treat lipodystrophy
• Study of reyataz in HIV-infected patients with lipodystrophy syndrome
• Introduction
  by Donald F. Richey
• Facial lipoatrophy trial
• The effect of Efudex treatment on photoaged skin
• Study of the efficacy, safety and tolerability of oral CEP-701 in patients with severe psoriasis
• Part 1 of a 2 part article: a comprehensive review of imatinib mesylate for dermatological diseases
  by Noah Schienfeld
• The incidence of recurrent herpes simplex and herpes zoster infection during treatment with arsenic trioxide
  by Keyvan Nouri
• Study to evaluate the Leish-111F + MPL-SE vaccine in the treatment of cutaneous leishmaniasis
• Acyclovir HSV skin, eye, and mouth
• Safety and effectiveness of efalizumab to treat oral lichen planus
• hOKT3gamma1 for the treatment of psoriatic arthritis
• Generic azithromycin approved by the FDA
• The position not the presence of the halogen in corticosteroids influences potency and side effects
  by Joseph Bikowski
• Paraffinomas of the facial area: treatment with systemic and intralesional steroids
  by Osvaldo Tomas Vazquez-Martinez
• Efficacy and safety of efalizumab in the treatment of moderate-severe hydradenitis suppurativa
• Ultraviolet B light therapy in the treatment of skin conditions with altered dermal matrix
• Efficacy of calcipotriol plus betamethasone gel vs. calcipotriol scalp solution in scalp psoriasis